Search

Although cell‐based therapy has become a promising treatment, its practice and evaluation process remain unstandardized. Therefore, Japan initiated a dual‐track regulatory framework for cell‐based therapy aiming to promote and regulate the therapies to ensure that patients can access safe and effective treatments. Influenced by such pathway, Taiwan adopted the framework and initiated its own cell‐based therapy regulation in 2018. This paper discusses how Japan has influenced Taiwan in developing regulations for cell‐based therapy. [ABSTRACT FROM AUTHOR]

This paper explores the location choice of multinational enterprises (MNEs) in China, shedding special light on the role of agglomeration of same-nationality firms. We examine how this role differs according to firms' productivity. Furthermore, we compare the location choice of Japanese and Taiwanese MNEs in China, taking into consideration that Taiwanese MNEs experience less uncertainty in investing in China due to Taiwan's linguistic and cultural advantages. When considering firms' productivity, we find that less productive Japanese firms prefer to locate close to larger same-nationality agglomerations while there are no differences in location choices in the case of Taiwanese firms. [ABSTRACT FROM AUTHOR]

As of 2008, surrogacy is legal and openly practised in various places; Japan, however, has no regulations or laws regarding surrogacy. This paper reports the situation of surrogacy in Japan and in five other regions (the USA, the UK, Taiwan, Korea and France) to clarify the pros and cons of prohibiting surrogacy, along with the problems and issues relating to surrogacy compensation. Not only in a country such as France that completely prohibits surrogacy within the country, but also in a country such as the UK that allows non-commercial surrogacy, infertile couples travel overseas for the purpose of surrogacy. In addition, some couples might seek underground surrogacy if the government prohibits surrogacy. If an intended parent couple and a surrogate make an agreement among themselves and then a problem occurs, they cannot ask for support from professionals or bring a case to court, as can be observed in South Korea and Taiwan. We also conclude that there is little difference between commercial surrogacy and non-commercial surrogacy in the absence of a clear definition of ‘reasonable expenses.’ In the UK, the law does not allow surrogates to receive compensation. However, in reality, there may be little difference between the amounts paid to surrogates for profit in the US and those paid to surrogates for reasonable expenses in the UK. We conclude that the issue of surrogacy demands further discussion in Japan. [ABSTRACT FROM AUTHOR]